Improvement in asthma control and inflammation in children undergoing adenotonsillectomy

Jonathan C Levin1, Lisa Gagnon2, Xiaoxuan He1

  • 1Section of Pulmonary and Critical Care, Yale University School of Medicine, New Haven, Connecticut.

Pediatric Research
|January 24, 2014
PubMed

Insights

Adenotonsillectomy improved asthma control in children, particularly those with high preoperative chitinase activity. This suggests the procedure impacts airway inflammation by modulating chitinase levels.

Area of Science:

  • Pediatric Otolaryngology
  • Respiratory Medicine
  • Biomarkers of Inflammation

Background:

  • Asthma control may improve post-adenotonsillectomy, but limited longitudinal data exists on airway inflammation biomarkers.
  • Adenotonsillectomy is a common procedure in children, with potential benefits for respiratory conditions.

Purpose of the Study:

  • To investigate the longitudinal effect of adenotonsillectomy on asthma control and chitinase activity.
  • To correlate pre-operative chitinase levels with post-operative asthma outcomes.

Main Methods:

  • A longitudinal observational study involving pediatric patients undergoing adenotonsillectomy.
  • Measurement of Asthma Control Test (ACT) scores and serum chitinase activity at baseline and 6-month follow-up.

Main Results:

  • Asthma Control Test scores significantly improved by 3 points post-surgery (P < 0.001).
  • 85% of poorly controlled asthmatics showed improved control or reduced healthcare utilization.
  • Chitinase activity decreased in asthmatics with improved control, and higher baseline levels predicted better outcomes (P < 0.01).

Conclusions:

  • Adenotonsillectomy significantly improves asthma control and reduces healthcare utilization in children with high baseline chitinase activity.
  • The procedure appears to modulate chitinase activity, suggesting an impact on airway inflammation and disease severity.
Abstract

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.2K
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
16.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
679
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Antiasthma Drugs: &#946;2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
2.1K